Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Preferred Stock [Member] Series C Preferred Stock [Member]	Preferred Stock [Member] Series D Preferred Stock [Member]	Preferred Stock [Member] Series E Preferred Stock [Member]	Preferred Stock [Member] Series F Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Beginning balance, value at Dec. 31, 2020					$ 67	$ 29,772	$ (44,612)		$ (14,773)
Balance, shares at Dec. 31, 2020	100	40	3,458	361	11,112,709
Accrued dividend						505	(882)		(377)
Issuance of common stock with term loan					$ 3	23			26
Issuance of common stock with term loan, shares					518,000
Issuance of warrants with convertible notes						28			28
Beneficial conversion feature convertible notes						19			19
Net income (loss)							(428)		(428)
Ending balance, value at Mar. 31, 2021					$ 70	30,347	(45,922)		(15,505)
Balance, shares at Mar. 31, 2021	100	40	3,458	361	11,630,709
Beginning balance, value at Dec. 31, 2020					$ 67	29,772	(44,612)		(14,773)
Balance, shares at Dec. 31, 2020	100	40	3,458	361	11,112,709
Net income (loss)									(942)
Conversion of Series E Preferred to common stock									1
Ending balance, value at Jun. 30, 2021					$ 71	30,417	(46,828)		(16,340)
Balance, shares at Jun. 30, 2021	100	40	3,450	361	11,785,290
Beginning balance, value at Mar. 31, 2021					$ 70	30,347	(45,922)		(15,505)
Balance, shares at Mar. 31, 2021	100	40	3,458	361	11,630,709
Issuance of warrants with convertible notes						69			69
Net income (loss)							(514)		(514)
Accrued and deemed dividend						11	(392)		(381)
Issuance of common stock for cashless exercise of warrants
Issuance of common stock for cashless exercise of warrants, shares					53,571
Issuance of common stock for Series E conversion					$ 1	9			10
Issuance of common stock for Series E conversion, shares			(8)		101,010
Ending balance, value at Jun. 30, 2021					$ 71	30,417	(46,828)		(16,340)
Balance, shares at Jun. 30, 2021	100	40	3,450	361	11,785,290
Beginning balance, value at Dec. 31, 2021					$ 102	27,809	(53,017)		(25,106)
Balance, shares at Dec. 31, 2021	100	40	3,326	358	16,988,836
Accrued dividend							(364)		(364)
Issuance of common stock with term loan					$ 2	26			28
Issuance of common stock with term loan, shares					254,401
Net income (loss)							(74)		(74)
Issuance of common stock with convertible notes					$ 1	17			18
Issuance of common stock with convertible notes, shares					250,000
Ending balance, value at Mar. 31, 2022					$ 105	27,852	(53,455)		(25,498)
Balance, shares at Mar. 31, 2022	100	40	3,326	358	17,493,237
Beginning balance, value at Dec. 31, 2021					$ 102	27,809	(53,017)		$ (25,106)
Balance, shares at Dec. 31, 2021	100	40	3,326	358	16,988,836
Issuance of common stock with term loan, shares									2,665,672
Net income (loss)									$ 25
Conversion of Series E Preferred to common stock									5,056
Ending balance, value at Jun. 30, 2022					$ 379	33,186	(53,558)	(2)	(19,995)
Balance, shares at Jun. 30, 2022	100	40	267		63,127,450
Beginning balance, value at Mar. 31, 2022					$ 105	27,852	(53,455)		(25,498)
Balance, shares at Mar. 31, 2022	100	40	3,326	358	17,493,237
Accrued dividend							(202)		(202)
Issuance of common stock with term loan					$ 2	9			11
Issuance of common stock with term loan, shares					384,615
Net income (loss)							99		99
Conversion of Series E Preferred to common stock					$ 244	4,812			5,056
Conversion of Series E Preferred to common stock, shares			(3,059)		40,706,120
Conversion of Series F Preferred to common stock					$ 28	513			541
Conversion of Series F Preferred to common stock, shares				(358)	4,662,524
Repurchase of common stock								(2)	(2)
Repurchase of common stock, shares					(119,046)
Ending balance, value at Jun. 30, 2022					$ 379	$ 33,186	$ (53,558)	$ (2)	$ (19,995)
Balance, shares at Jun. 30, 2022	100	40	267		63,127,450